<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04751552</url>
  </required_header>
  <id_info>
    <org_study_id>L20.047</org_study_id>
    <nct_id>NCT04751552</nct_id>
  </id_info>
  <brief_title>Erector Spinae Block for Thoracoscopic Surgery</brief_title>
  <official_title>Effect of Erector Spinae Plane Block on Postoperative Pain Intensity in Patients Undergoing Thoracoscopic Surgery: a Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Antonius Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Antonius Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized clinical trial compares the effects of the erector spinae plane block with&#xD;
      levobupivacaine and 0,9% saline on postoperative pain intensity, and opioid consumptions&#xD;
      following thoracoscopic pulmonary surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty patients planned for thoracoscopic pulmonary surgery are randomly assigned to an&#xD;
      erector spinae plane block (ESPB) with levobupivacaine (intervention group) or 0,9% saline&#xD;
      (control group). ESPB is performed under general anaesthesia before surgery.&#xD;
&#xD;
      Postoperative pain medication incudes acetominophen, NSAIDs en parenteral morphine (patient&#xD;
      controlled analgesia).&#xD;
&#xD;
      Following surgery pain intensity (numeric rating scale) is registered at the recovery ward&#xD;
      one hour after surgery. Furthermore, pain intensity is registered 2,4,8, 12 hours after the&#xD;
      operation. On the first postoperative day, pain intensity is registered at 8.00 o'cock AM and&#xD;
      8.00 o'clock PM. Opioid consumption is registered as a second parameter of postoperative&#xD;
      pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled double blind trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity (numeric rating scale (NRS) (0=no pain up to 10=most pain imaginable) 2 hours after surgery.</measure>
    <time_frame>2 hours postoperatively</time_frame>
    <description>Pain level 2 hours after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity (NRS) 4 hours after surgery.</measure>
    <time_frame>4 hours postoperatively</time_frame>
    <description>Pain level 4 hours after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity (NRS) 8 hours after surgery.</measure>
    <time_frame>8 hours postoperatively</time_frame>
    <description>Pain level 8 hours after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity (NRS) 12 hours after surgery.</measure>
    <time_frame>12 hours postoperatively</time_frame>
    <description>Pain level twelve hours after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity (NRS) at 8.00 o'clock on the first postoperative day</measure>
    <time_frame>At 8 o'clock AM on the first postoperative day</time_frame>
    <description>Pain level at 8.00 o'clock on the first postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity (NRS) at 20.00 o'clock on the first postoperative day</measure>
    <time_frame>At 8 o'clock PM on the first postoperative day</time_frame>
    <description>Pain level at 20.00 o'clock on the first postoperative day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>First 48 hours after surgery, recorded following disconnection of the PCA device at 8 o'clock AM on the second postoperative day.</time_frame>
    <description>Parenteral morphine use (mg) as recorded by the Patient-Controlled Analgesia (PCA) device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in recovery ward (minutes)</measure>
    <time_frame>First 48 hours after surgery</time_frame>
    <description>length of stay in recovery ward (minutes) after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction of pain therapy</measure>
    <time_frame>Measurement in the morning of the second postoperative day</time_frame>
    <description>Patient satisfaction of pain therapy (numeric rating scale 0-10(0=severely dissatisfied up to 10= maximally satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of side effects</measure>
    <time_frame>First 48 hours</time_frame>
    <description>Daily scoring of side effects (nausea, drowsiness, pruritus, other (yes/no))</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Thoracic Neoplasms</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive an ESPB with the local anaesthetic levobupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive an ESPB with 0,9% saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector Spinae Plane Block (for postoperative pain relief)</intervention_name>
    <description>A ultrasound guided single bolus injection of 20 ml of levobupivacaine or placebo between the erector spinae muscle and process transversus of vertebra T5.</description>
    <arm_group_label>Levobupivacaine group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for thoracoscopic pulmonary sleeve resection or lobectomy&#xD;
&#xD;
          -  Age 18 years or older&#xD;
&#xD;
               -  American Society of Anesthesiologists (ASA) health status class I-III&#xD;
&#xD;
               -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication for regional analgesia (e.g. coagulopathy, infection at injection&#xD;
             site)&#xD;
&#xD;
          -  Contraindication for NSAIDs&#xD;
&#xD;
          -  Chronic opioid use&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leon Timmerman, M.D., PhD</last_name>
    <phone>0031625064311</phone>
    <email>l.timmerman@antoniusziekenhuis.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pauline Nijk, M.D.</last_name>
    <email>p.nijk@antoniusziekenhuis.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leon Timmerman, M.D., PhD</last_name>
      <phone>0031625064311</phone>
      <email>l.timmerman@antoniusziekenhuis.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Antonius Hospital</investigator_affiliation>
    <investigator_full_name>Leon Timmerman</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Thoracoscopy</keyword>
  <keyword>Pain</keyword>
  <keyword>Regional anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thoracic Neoplasms</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Relevant participant data underlying the final results and conclusions of the study.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Following the report of the study</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

